More often, they can be traced back to much earlier decisions about where a study should run in the first place. That’s because, while a country may offer promising patient population numbers, investigator experience, site infrastructure, operational maturity, and the ability to deliver increasingly complex protocols can vary significantly, resulting in challenges that only emerge once a study is underway. Drawing on global site intelligence and early engagement insight, the conversation explores how sponsors can mitigate recruitment and delivery risk upstream. Watch the video today to hear how IQVIA is helping sponsors to test assumptions before countries are selected, identifying where patient populations, experienced investigators, and operational readiness truly align. IQVIA is a global leader in protecting individual patient privacy.